cp wire

CP Wire Articles

Imbrium Therapeutics and Mundipharma EDO Announce Orphan Drug Designation for Relapsed Refractory Biliary Tract Cancer Treatment



Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., in conjunction with Mundipharma EDO GmbH, announced on 2/21/19 that the U.S. Food and Drug Administration (FDA)... read more

Fri, 02/22/19 - 09:46 am
Outlook Therapeutics Files for $57 Million Offering

On 2/21/19 Outlook Therapeutics filed for a $57 million offering in part to support its treatment for wet AMD (age related macular degeneration). The filing did not specify the number of shares to... read more

Thu, 02/21/19 - 10:49 am
Microbiome Report for Week Ending 2/16/19

SkinBioTherapeutics to Seeking New CEO
On 2/14/19 SkinBioTherapeutics... read more

Wed, 02/20/19 - 02:23 pm
Pfizer drops higher dose treatment arm in Xeljanz post-marketing study due to safety issues

Pfizer’s Xeljanz (tofacitinib), used to treat conditions such as rheumatoid arthritis and ulcerative colitis, has... read more
Wed, 02/20/19 - 11:50 am
Microbiome Company Kaleido Biosciences Announces $120 Million IPO

On 2/19/18 Kaleido Biosciences filed for a $120 Million IPO. The company will offer 4,761,905 shares of  common stock. The expected price is between $20 and $22 per share. The shares will be... read more

Tue, 02/19/19 - 09:53 am

Pages